Eris Lifesciences - On An Acquisition Spree To Enhance Derma Portfolio: Motilal Oswal

Deal to be EPS neutral over the medium term.

<div class="paragraphs"><p>Capsule strips. (Source:</p></div>
Capsule strips. (Source:
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.  
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More